Nephrocare Health Services logo

Nephrocare Health Services financials: balance sheet, profit and loss, cash flow

NSE: NEPHROPLUSBSE: 544647Healthcare ServicesSmall Cap

Nephrocare Health Services Limited · Face value ₹2 · Listed Dec 2025 · Issue price ₹460
Last close ₹628.40down ₹6.20 (0.98%)BSE ₹628.00

Share price at the NSE close on 28 Oct 2026. Previous close ₹634.60.

28 Oct: open ₹634.60, high ₹637.90, low ₹625.45

Range of traded prices from listing on 17 Dec 2025 to 28 Oct 2026
₹446.00Low, 19 Dec 2025₹781.50High, 11 Sep 2026
Market cap
₹6,319 Cr739th largest listed
P/E
No full year
P/B
5.66
Dividend yield
Nonesince listing in Dec 2025
Debt to equity
0.07
Volume, NSE
59,02543.2% delivered

Nephrocare Health Services' financial statements for the year to Mar 2026, consolidated: the company and its subsidiaries together.

1 year at a glance

₹ crore, years to March.Nephrocare Health Services annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
9997780Mar 26

Operating and net margin, per cent

  • Operating margin
  • Net margin
22.7%7.7%22.7%7.7%Mar 26

Results for the year to Mar 2026

Consolidated: the company and its subsidiaries together. ₹ crore.

From revenue to net profit

  1. Revenue999
  2. Materials and goods−227
  3. Employee costs−172
  4. Other expenses−373
  5. Operating profit227
  6. Depreciation−91
  7. Other income+25
  8. One-off items0.0
  9. Finance costs−60
  10. Profit before tax101
  11. Tax−21
  12. Joint ventures−3.1
  13. Net profit77

What the company owns

  • Plant, investments and other assets₹695 Cr
  • Receivables₹317 Cr
  • Cash and bank₹255 Cr
  • Current investments₹171 Cr
  • Inventory₹33 Cr

What pays for it: net worth and liabilities

  • Net worth₹1,116 Cr
  • Owed to suppliers₹143 Cr
  • Other liabilities₹132 Cr
  • Borrowings₹80 Cr

Profit and loss

Consolidated, ₹ crore, years to March.Nephrocare Health Services quarterly results

₹ croreMar 2026Filed 19 May
Revenue from operations999
772
Materials and goods bought227
Employee costs172
Other expenses373
Operating profit before depreciation227
Operating margin22.7%
Materials, % of revenue22.7%
Employee costs, % of revenue17.2%
Other expenses, % of revenue37.4%
Depreciation and amortisation91
Operating profit after depreciation136
Other income25
Finance costs60
One-off items0
Profit before tax101
21
Share of profit of joint ventures and associates−3
Net profit77
Other comprehensive income19
Total comprehensive income95
Net margin7.7%
Net margin without joint ventures and associates8.0%

Balance sheet

Consolidated, ₹ crore, at 31 March.

₹ croreMar 2026Filed 19 May
1,116
Share capital20
Reserves1,096
80
299
55
Total assets1,471
632
839
Net debt−346
Borrowings are counted again inside the liabilities due within a year and after a year.

Cash flow

Consolidated, ₹ crore, years to March.

₹ croreMar 2026Filed 19 May
233
260
−6
Receivables−69
Inventories−5
Payables33
Other working capital36
Tax paid−27
Capital spending119
Free cash flow114
−410
157
Dividends paid0
Shares bought back0
Shares issued390
Net change in cash−21
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only.

Per share

Consolidated, ₹ per share, years to March.

₹ per shareMar 2026Filed 19 May
Earnings per share₹8.48
Diluted earnings per share₹8.10
Book value per share₹111.27
Shareholder yield−7.7%
Market cap at the year end (₹ crore)5,086

Ratios

Consolidated, years to March.Nephrocare Health Services PE ratio and valuation

RatioMar 2026Filed 19 May
Return on equity6.9%
Return on capital employed11.4%
Cash conversion302.7%
Interest cover2.3
Debt to equity0.07
Receivable days116
Inventory days53
Payable days230
Cash conversion cycle, days−61
Working capital days54
Asset turnover0.68
Assets per rupee of net worth1.32
Sales per rupee of plant2.52
Capital spending to depreciation1.31
Plant being built, % of plant in use1.4%

Growth and returns over 3, 5 and 10 years

Consolidated: the company and its subsidiaries together. Each window ends with the year to Mar 2026.

Return on assets, latest year
5.2%
Cash from operations against operating profit
102.5%

Where the cash came from and went

Consolidated: the company and its subsidiaries together. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ croreLatest year
Cash from operations233
Cash from investing−410
Cash from financing157
Capital spending119
Dividends paid0
Shares bought back0
Shares issued for cash390
Borrowings raised0
Borrowings repaid203

Accounting checks

Consolidated, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2026
Altman Z-scorePublished threshold 1.8111.13
Effective tax ratePublished threshold 17.16 per cent20.52
Tax charged less tax paid, % of profitOur threshold 10 percentage points−6.80
A threshold marked as ours has no published figure; it is the line we read the check against.

Credit ratings

An agency's view of the chance the company repays a borrowing on time, from AAA, the highest, down to D, in default.

DateAgencyBorrowing ratedRatingOutlookAmount, ₹ Cr
18 Sep 2026India Ratings and Research Private LimitedBank loan facilitiesIND AA-; IND A1+New, NewStable50.66
The latest rating on each borrowing. The agency's name opens its reasoning for the rating.